Literature DB >> 11889168

Loss of body cell mass in Cushing's syndrome: effect of treatment.

Matthias Pirlich1, Henrik Biering, Helga Gerl, Manfred Ventz, Bernd Schmidt, Siegfried Ertl, Herbert Lochs.   

Abstract

Cushing's syndrome (CS) is associated with low fat-free mass, but it is unclear whether hypercortisolism causes a loss of whole body protein. Body composition was studied prospectively in 15 patients with untreated CS (n = 14 pituitary adenoma; n = 1 adrenal adenoma), in 15 nonobese healthy controls, and in 15 weight-matched obese controls by 3 different methods: total body potassium counting (TBP), bioelectrical impedance analysis (BIA), and anthropometry. In 6 patients, body composition was studied before and within 6 months after pituitary surgery. In CS patients and weight-matched controls, body weight and total body fat were significantly higher than in nonobese controls. In CS patients, TBP was 18.4% lower than predicted, whereas in weight-matched controls TBP was 7.1% higher than predicted. As compared with nonobese and weight-matched controls, in CS patients TBP indicated a significant loss of body cell mass (BCM) of -20.2 and -21.1%, respectively. A significantly reduced arm muscle area of -21.3% compared with weight-matched controls also indicated a loss of whole body protein. In CS, however, BIA overestimated BCM when compared with TBP by +18% and agreement between BIA and TBP in the individual patient was poor (limits of agreement plus minus 27.6%), indicating the invalidity of standard BIA equations in this population. Measurements performed before and 6 months after successful pituitary surgery demonstrated a significant loss of body weight (-11%) and body fat (-33%), but BCM and muscle mass remained on a constant low level. In conclusion, this study shows that, in patients with CS, a significantly reduced BCM indicates a true protein loss. The second interesting finding is that in the early recovery after successful treatment of hypercortisolism patients lose body fat without gaining BCM or muscle mass.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889168     DOI: 10.1210/jcem.87.3.8321

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Diagnostic work-up in steroid myopathy.

Authors:  Marco Alessandro Minetto; Valentina D'Angelo; Emanuela Arvat; Santosh Kesari
Journal:  Endocrine       Date:  2017-11-15       Impact factor: 3.633

2.  Four-compartment cellular level body composition model: comparison of two approaches.

Authors:  Wei Shen; Marie-Pierre St-Onge; Angelo Pietrobelli; Jack Wang; ZiMian Wang; Stanley Heshka; Steven B Heymsfield
Journal:  Obes Res       Date:  2005-01

3.  Glucocorticoid treatment, immobility, and constipation are associated with nutritional risk.

Authors:  Jean-Pierre Gutzwiller; Josef Aschwanden; Samuel Iff; Michèle Leuenberger; Martin Perrig; Zeno Stanga
Journal:  Eur J Nutr       Date:  2011-03-03       Impact factor: 5.614

4.  Anthropometric measures and fasting insulin levels in children before and after cure of Cushing syndrome.

Authors:  Margaret F Keil; Jennifer Graf; Nirmal Gokarn; Constantine A Stratakis
Journal:  Clin Nutr       Date:  2011-12-07       Impact factor: 7.324

5.  Body composition and cardiovascular risk markers after remission of Cushing's disease: a prospective study using whole-body MRI.

Authors:  Eliza B Geer; Wei Shen; Erika Strohmayer; Kalmon D Post; Pamela U Freda
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

6.  Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study.

Authors:  Karina Danilowicz; Oscar Domingo Bruno; Marcos Manavela; Reynaldo Manuel Gomez; Ariel Barkan
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

7.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2015-07-29       Impact factor: 5.958

8.  Ultrasound-based detection of glucocorticoid-induced impairments of muscle mass and structure in Cushing's disease.

Authors:  M A Minetto; C Caresio; M Salvi; V D'Angelo; N E Gorji; F Molinari; G Arnaldi; S Kesari; E Arvat
Journal:  J Endocrinol Invest       Date:  2018-11-15       Impact factor: 4.256

Review 9.  The pituitary-adrenal axis and body composition.

Authors:  Eva Fernandez-Rodriguez; Paul M Stewart; Mark S Cooper
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

10.  The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes.

Authors:  Marc G Jeschke; Felicia N Williams; Celeste C Finnerty; Noe A Rodriguez; Gabriela A Kulp; Arny Ferrando; William B Norbury; Oscar E Suman; Robert Kraft; Ludwik K Branski; Ahmed M Al-mousawi; David N Herndon
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.